Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study;Prácticas de cribado de cáncer y estilos de vida asociados en la población de controles del estudio español multi-caso control (MCC-Spain)

Gaceta Sanitaria

Volumn 26, Issue 4, 2012, Pages 301-310

  Dolores Perea, M ^a   Castaño Vinyals, Gemma ^a,b,c   Altzibar, Jone M ^c,d   Ascunce, Nieves ^c,e   Moreno, Víctor ^c,f   Tardon, Adonina ^c,g   Pollán, Marina ^c,h   Perea, M Dolores ^a   Aragonés, Nuria ^c,h   Sala, Maria ^a,c   Castells, Antoni ^c,i   Castells, Xavier ^a,c   Kogevinas, Manolis ^c,j,k  

^a HOSPITAL DEL MAR   (Spain)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d Subdirección de Salud Pública de Gipuzkoa   (Spain)

^e INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^f CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^g UNIVERSITY OF OVIEDO   (Spain)

^h CARLOS III INSTITUTE OF HEALTH   (Spain)

ⁱ HOSPITAL CLÍNIC   (Spain)

^j INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^k NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

more..

Author keywords

Comorbidity; Early detection of cancer; Lifestyle; Mammography; Mass screening; Prostate specific antigen; Risk factors

Indexed keywords

EID: 84863227812     PISSN: 02139111     EISSN: 15781283     Source Type: Journal    
DOI: 10.1016/j.gaceta.2012.01.020     Document Type: Article

References (30)

1. Ascunce N., Salas D., Zubizarreta R., et al. Cancer screening in Spain. Annals of Oncology 2010, 21(Suppl 3):43-51.
2. Encuesta Europea de Salud en España 2009. Madrid: Instituto Nacional de Estadística. (Actualizado en Nov de 2010; citado en Abr de 2011.) Disponible en: . http://www.ine.es/.
3. Hewitson P., Glasziou P., Irwig L., et al. Screening for colorectal cancer using the faecal occult blood test. Hemoccult. Cochrane Database Syst Rev 2007, 24:CD001216.
4. Proposal for a council recommendation on cancer screening. 2003/0093 (CNS). Brussels 2003, Commission of the European Communities.
5. Djulbegovic M., Beyth R.J., Neuberger M., et al. Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ 2010, 341:c4543.
6. Cepeda J., Ribas M., Fuente E., et al. Ventajas y riesgos de la utilización del antígeno específico de próstata (PSA) en el área sanitaria V de Gijón (Asturias). Arch Esp Urol 2005, 58:403-411.
7. Martín-López R., Hernández-Barrera V., De Andrés A.L., et al. Breast and cervical cancer screening in Spain and predictors of adherence. Eur J Cancer Prev 2010, 19:239-245.
8. Fredman L., Sexton M., Cui Y., et al. Cigarette smoking, alcohol consumption, and screening mammography among women ages 50 and older. Prev Med 1999, 28:407-417.
9. Maruthur N.M., Bolen S., Brancati F.L., et al. Obesity and mammography: a sistematic review and meta-analysis. J Gen Intern Med 2009, 24:665-677.
10. Coups E., Manne S.L., Meropol N.J., et al. Multiple behavioral risk factors for colorectal cancer and colorectal cancer screening status. Cancer Epidemiol Biomarkers Prev 2007, 16:510-516.
11. Coughlin S.S., Uhler R.J., Hall I.H., et al. Nonadherence to breast and cervical cancer screening: what are the linkages to chronic disease risk?. Preventing Chronic Disease 2004, [edición electrónica]. (Citado en Abr de 2011.) Disponible en: http://www.cdc.gov/pcd/issues/2004/jan/03_0015.htm.
12. Lemon S., Zapka J., Puleo E., et al. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Am J Public Health 2001, 91:1264-1272.
13. Kushi L.H., Byers T., Doyle C., et al. American Society Guidelines on nutrition and physical activity. CA Cancer J Clin 2006, 56:254-281. The American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee.
14. Martín-Moreno J.M., Boyle P., Gorgojo L., et al. Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol 1993, 22:512-519.
15. Europe against cancer action plan, 1987-1989. Oficial J Eur Community 1987, 1-58. Commission of the European Community, 87/C50/01.
16. Armstrong K., Moye E., Williams S., et al. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 2007, 146:516-526.
17. Castells X., Sala M., Salas D., et al. Reflexiones sobre las prácticas de diagnóstico precoz del cáncer en España. Gac Sanit 2009, 23:244-249.
18. Winawer S., Fletcher R., Rex D., et al. Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003, 124:544-560.
19. Griffin J.M., Burgess D., Vernon S., et al. Are gender differences in colorectal cancer screening rates due to differences in self-reporting?. Prev Med 2009, 49:436-441.
20. Draisma G., Etzioni R., Tsodikov A., et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst 2009, 101:374-383.
21. Gorin S.S., Jacobson J. Diet and breast cancer surveillance behaviors among Harlem women. Ann N Y Acad Sci 2001, 952:153-160.
22. López-de-Andrés A., Martín-López R., Hernández-Barrera V., et al. Predictors of breast and cervical cancer screening in a Spanish metropolitan area. J Womens Health (Larchmt) 2010, 19:1675-1681.
23. Beydoun H.A., Beydoun M.A. Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control 2008, 19:339-359.
24. Jiménez-García R., Hernández-Barrera V., Carrasco-Garrido P., et al. Prevalence and predictors of breast and cervical cancer screening among Spanish women with diabetes. Diabetes Care 2009, 32:1470-1472.
25. Ross L.E., Taylor Y.J., Richardson L.C., et al. Patterns in prostate-specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002-2006. J Natl Med Assoc 2009, 101:316-324.
26. Power E., Miles A., von Wagner C., et al. Uptake of colorectal cancer screening: system, provider and individual factors and strategies to improve participation. Future Oncol 2009, 5:1371-1388.
27. Duport N., Serra D., Goulard H., et al. Which factors influence screening practices for female cancer in France?. Rev Epidemiol Sante Publique 2008, 56:303-313.
28. Carlos R.C., Fendrick A.M., Ellis J., et al. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?. J Am Coll Radiol 2004, 1:769-776.
29. Rauscher G.R., Johnson T.P., Cho Y., et al. Accuracy of self-reported cancer screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008, 17:748-757.
30. Esteva M., Ripoll J., Leiva A., et al. Determinants of non attendance to mammography program in a region with high voluntary health insurance coverage. BMC Public Health 2008, 8:387.